American Journal of Ophthalmology
Volume 146, Issue 6 , Pages 819-827.e2 , December 2008

Uveitis Associated With Pediatric Behçet Disease in the American Midwest

,Accepted 26 May 2008.

References 

  1. O'Duffy JD. Behçet's disease. Curr Opin Rheumatol. 1994;6:39–43
  2. Japan BsDCo. Behçet's Disease: guide to diagnosis of Behçet's Disease. Jpn J Ophthalmol. 1974;18:291–294
  3. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet. 1990;335:1078–1080
  4. Mishima S, Masuda K, Izawa Y, Mochizuki M, Namba K. The eighth Frederick H. Verhoeff Lecture. Presented by Saiichi Mishima, MD. Behçet's disease in Japan: ophthalmologic aspects. Trans Am Ophthalmol Soc. 1979;77:225–279
  5. Kone-Paut I, Bernard JL. Behçet disease in children in France. Arch Fr Pediatr (French). 1993;50:561–565
  6. Eldem B, Onur C, Ozen S. Clinical features of pediatric Behçet's disease. J Pediatr Ophthalmol Strabismus. 1998;35:159–161
  7. Yazici H, Tuzun Y, Pazarli H, et al. Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behçet's syndrome. Ann Rheum Dis. 1984;43:783–789
  8. Pivetti-Pezzi P, Accorinti M, Abdulaziz MA, La Cava M, Torella M, Riso D. Behçet's disease in children. Jpn J Ophthalmol. 1995;39:309–314
  9. Kone-Paut I, Yurdakul S, Bahabri SA, et al. Clinical features of Behçet's disease in children: an international collaborative study of 86 cases. J Pediatr. 1998;132:721–725
  10. Krause I, Uziel Y, Guedj D, et al. Childhood Behçet's disease: clinical features and comparison with adult-onset disease. Rheumatology (Oxford). 1999;38:457–462
  11. Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data (Results of the First International Workshop). Am J Ophthalmol. 2005;140:509–516
  12. Tugal-Tutkun I, Havrlikova K, Power WJ, Foster CS. Changing patterns in uveitis of childhood. Ophthalmology. 1996;103:375–383
  13. Borlu M, Uksal U, Ferahbas A, Evereklioglu C. Clinical features of Behçet's disease in children. Int J Dermatol. 2006;45:713–716
  14. Lang BA, Laxer RM, Thorner P, Greenberg M, Silverman ED. Pediatric onset of Behçet's syndrome with myositis: case report and literature review illustrating unusual features. Arthritis Rheum. 1990;33:418–425
  15. Hamdan A, Mansour W, Uthman I, Masri AF, Nasr F, Arayssi T. Behçet's disease in Lebanon: clinical profile, severity and two-decade comparison. Clin Rheumatol. 2006;25:364–367
  16. Ozdal PC, Ortac S, Taskintuna I, Firat E. Posterior segment involvement in ocular Behçet's disease. Eur J Ophthalmol. 2002;12:424–431
  17. Tugal-Tutkun I, Urgancioglu M. Childhood-onset uveitis in Behçet disease: a descriptive study of 36 cases. Am J Ophthalmol. 2003;136:1114–1119
  18. Kitaichi N, Miyazaki A, Iwata D, Ohno S, Stanford MR, Chams H. Ocular features of Behçet's disease: an international collaborative study. Br J Ophthalmol. 2007;91:1579–1582
  19. Allali F, Benomar A, Karim A, et al. Behçet's disease in Moroccan children: a report of 12 cases. Scand J Rheumatol. 2004;33:362–363
  20. Evereklioglu C, Yurekli M, Er H, et al. Increased plasma adrenomedullin levels in patients with Behçet's disease. Dermatology. 2000;201:312–315
  21. Evereklioglu C, Inaloz HS, Kirtak N, et al. Serum leptin concentration is increased in patients with Behçet's syndrome and is correlated with disease activity. Br J Dermatol. 2002;147:331–336
  22. Evereklioglu C, Turkoz Y, Er H, Inaloz HS, Ozbek E, Cekmen M. Increased nitric oxide production in patients with Behçet's disease: is it a new activity marker?. J Am Acad Dermatol. 2002;46:50–54
  23. Yazici H, Chamberlain MA, Tuzun Y, Yurdakul S, Muftuoglu A. A comparative study of the pathergy reaction among Turkish and British patients with Behçet's disease. Ann Rheum Dis. 1984;43:74–75
  24. Dogan B, Taskapan O, Harmanyeri Y. Prevalance of pathergy test positivity in Behçet's disease in Turkey. J Eur Acad Dermatol Venereol. 2003;17:228–229
  25. Gurler A, Boyvat A, Tursen U. Clinical manifestations of Behçet's disease: an analysis of 2,147 patients. Yonsei Med J. 1997;38:423–427
  26. Ozdemir M, Bodur S, Engin B, Baysal I. Evaluation of application of multiple needle pricks on the pathergy reaction. Int J Dermatol. 2008;47:335–338
  27. Mamo JG. Treatment of Behçet disease with chlorambucil (A follow-up report). Arch Ophthalmol. 1976;94:580–583
  28. Mamo JG, Azzam SA. Treatment of Behçet's disease with chlorambucil. Arch Ophthalmol. 1970;84:446–450
  29. Mudun BA, Ergen A, Ipcioglu SU, Burumcek EY, Durlu Y, Arslan MO. Short-term chlorambucil for refractory uveitis in Behçet's disease. Ocul Immunol Inflamm. 2001;9:219–229
  30. Goldstein DA, Fontanilla FA, Kaul S, Sahin O, Tessler HH. Long-term follow-up of patients treated with short-term high-dose chlorambucil for sight-threatening ocular inflammation. Ophthalmology. 2002;109:370–377
  31. Tessler HH, Jennings T. High-dose short-term chlorambucil for intractable sympathetic ophthalmia and Behçet's disease. Br J Ophthalmol. 1990;74:353–357
  32. Kauppi MJ, Savolainen HA, Anttila VJ, Isomaki HA. Increased risk of leukaemia in patients with juvenile chronic arthritis treated with chlorambucil. Acta Paediatr. 1996;85:248–250
  33. Palmer RG, Denman AM. Malignancies induced by chlorambucil. Cancer Treat Rev. 1984;11:121–129
  34. Rosenbaum JT. Blind insight: eyeing anti-tumor necrosis factor treatment in uveitis associated with Behçet's disease. J Rheumatol. 2004;31:1241–1243
  35. Sfikakis PP, Markomichelakis N, Alpsoy E, et al. Anti-TNF therapy in the management of Behçet's disease—review and basis for recommendations. Rheumatology (Oxford). 2007;46:736–741
  36. Guillaume-Czitrom S, Berger C, Pajot C, Bodaghi B, Wechsler B, Kone-Paut I. Efficacy and safety of interferon-alpha in the treatment of corticodependent uveitis of paediatric Behçet's disease. Rheumatology (Oxford). 2007;46:1570–1573
  37. Pivetti-Pezzi P, Accorinti M, Pirraglia MP, Priori R, Valesini G. Interferon alpha for ocular Behçet's disease. Acta Ophthalmol Scand. 1997;75:720–722
  38. Kotter I, Zierhut M, Eckstein AK, et al. Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis. Br J Ophthalmol. 2003;87:423–431

PII: S0002-9394(08)00429-7

doi: 10.1016/j.ajo.2008.05.043

American Journal of Ophthalmology
Volume 146, Issue 6 , Pages 819-827.e2 , December 2008

Article Tools